Search Results

There are 12076 results for: content related to: Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients

  1. You have free access to this content
    Abstracts: Turkish Society of Molecular Medicine, Third International Congress of Molecular Medicine, May 5–8, 2009, Istanbul, Turkey

    IUBMB Life

    Volume 61, Issue 3, March 2009, Pages: 273–389, Prof. Dr. Turgay Isbir

    Version of Record online : 25 FEB 2009, DOI: 10.1002/iub.183

  2. Genetic and environmental determinants of the PON-1 phenotype

    European Journal of Clinical Investigation

    Volume 37, Issue 3, March 2007, Pages: 187–196, M. Roest, T. M. Van Himbergen, A. B. Barendrecht, P. H. M. Peeters, Y. T. Van Der Schouw and H. A. M. Voorbij

    Version of Record online : 26 FEB 2007, DOI: 10.1111/j.1365-2362.2007.01769.x

  3. You have free access to this content
    Efavirenz modulation of sleep spindles and sleep spectral profile

    Journal of Sleep Research

    Volume 24, Issue 1, February 2015, Pages: 66–73, Arthur A. Simen, Junshui Ma, Vladimir Svetnik, David Mayleben, James Maynard, Adam Roth, Lori Mixson, Robin Mogg, David Shera, Laura George, T. Chris Mast, Chan Beals, Aubrey Stoch, Arie Struyk, Norah Shire and Iain Fraser

    Version of Record online : 12 AUG 2014, DOI: 10.1111/jsr.12196

  4. Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 3, September 2011, Pages: 406–413, E Ngaimisi, S Mugusi, O Minzi, P Sasi, K-D Riedel, A Suda, N Ueda, M Janabi, F Mugusi, W E Haefeli, L Bertilsson, J Burhenne and E Aklillu

    Version of Record online : 3 AUG 2011, DOI: 10.1038/clpt.2011.129

  5. You have free access to this content
    Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy


    Volume 54, Issue 3, 2 September 2011, Pages: 1009–1019, Nadezda Apostolova, Leysa J. Gomez-Sucerquia, Anna Gortat, Ana Blas-Garcia and Juan V. Esplugues

    Version of Record online : 2 AUG 2011, DOI: 10.1002/hep.24459

  6. Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 494–502, M Siccardi, L Almond, A Schipani, C Csajka, C Marzolini, C Wyen, N H Brockmeyer, M Boffito, A Owen and D Back

    Version of Record online : 18 JUL 2012, DOI: 10.1038/clpt.2012.61

  7. The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 151–156, LB Avery, RP Bakshi, YJ Cao and CW Hendrix

    Version of Record online : 1 JUN 2011, DOI: 10.1038/clpt.2011.99

  8. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines

    Journal of Cellular Biochemistry

    Volume 103, Issue 5, 1 April 2008, Pages: 1524–1535, Bryan F. Curtin, Karthik I. Seetharam, Pilin Dhoieam, Richard K. Gordon, Bhupendra P. Doctor and Madhusoodana P. Nambiar

    Version of Record online : 19 SEP 2007, DOI: 10.1002/jcb.21543

  9. You have free access to this content
    The activity of paraoxonase type 1 (PON-1) in boar seminal plasma and its relationship with sperm quality, functionality, and in vivo fertility


    Volume 3, Issue 2, March 2015, Pages: 315–320, I. Barranco, A. Tvarijonaviciute, C. Perez-Patiño, D. V. Alkmin, J. J. Ceron, E. A. Martinez, H. Rodriguez-Martinez and J. Roca

    Version of Record online : 19 JAN 2015, DOI: 10.1111/andr.309

  10. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

    Intervention Review

    The Cochrane Library

    Lawrence CE Mbuagbaw, James H Irlam, Alicen Spaulding, George W Rutherford and Nandi Siegfried

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD004246.pub3

  11. Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenz

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 87–96, A.M. Abdelhady, Z. Desta, F. Jiang, C.W. Yeo, J.G. Shin and B.R. Overholser

    Version of Record online : 19 NOV 2013, DOI: 10.1002/jcph.208

  12. You have free access to this content
    Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells

    British Journal of Pharmacology

    Volume 160, Issue 8, August 2010, Pages: 2069–2084, N Apostolova, LJ Gomez-Sucerquia, A Moran, A Alvarez, A Blas-Garcia and JV Esplugues

    Version of Record online : 7 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00866.x

  13. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti–High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease

    Arthritis & Rheumatology

    Volume 68, Issue 6, June 2016, Pages: 1367–1376, Javier Rodríguez-Carrio, Raquel López-Mejías, Mercedes Alperi-López, Patricia López, Francisco J. Ballina-García, Miguel Á. González-Gay and Ana Suárez

    Version of Record online : 26 MAY 2016, DOI: 10.1002/art.39609

  14. Measurement of activity and concentration of paraoxonase 1 (PON-1) in seminal plasma and identification of PON-2 in the sperm of boar ejaculates

    Molecular Reproduction and Development

    Volume 82, Issue 1, January 2015, Pages: 58–65, Isabel Barranco, Jordi Roca, Asta Tvarijonaviciute, Marie Rubér, Alejandro Vicente-Carrillo, Mohammad Atikuzzaman, Jose J. Ceron, Emilio A. Martinez and Heriberto Rodriguez-Martinez

    Version of Record online : 8 DEC 2014, DOI: 10.1002/mrd.22444

  15. You have free access to this content
    Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 244–253, Fen Jiang, Zeruesenay Desta, Ji-Hong Shon, Chang-Woo Yeo, Ho-Sook Kim, Kwang-Hyeon Liu, Soo-Kyung Bae, Sang-Seop Lee, David A. Flockhart and Jae-Gook Shin

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04314.x

  16. You have full text access to this OnlineOpen article
    Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

    HIV Medicine

    A Bamford, A Turkova, H Lyall, C Foster, N Klein, D Bastiaans, D Burger, S Bernadi, K Butler, E Chiappini, P Clayden, M Della Negra, V Giacomet, C Giaquinto, D Gibb, L Galli, M Hainaut, M Koros, L Marques, E Nastouli, T Niehues, A Noguera-Julian, P Rojo, C Rudin, HJ Scherpbier, G Tudor-Williams, SB Welch and (PENTA Steering Committee)

    Version of Record online : 3 FEB 2015, DOI: 10.1111/hiv.12217

  17. You have free access to this content
    Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients

    British Journal of Clinical Pharmacology

    Volume 48, Issue 5, November 1999, Pages: 712–715, Villani, Regazzi, Castelli, Viale, Torti, Seminari and Maserati

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00071.x

  18. Rapid identification of efavirenz metabolites in rats and humans by ultra high performance liquid chromatography combined with quadrupole time-of-flight tandem mass spectrometry

    Journal of Separation Science

    Volume 38, Issue 9, May 2015, Pages: 1529–1536, Yachen Deng, Rong Liu, Ping Yang and Jianying Liang

    Version of Record online : 26 MAR 2015, DOI: 10.1002/jssc.201401401

  19. Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo Correlation

    Advanced Healthcare Materials

    Volume 3, Issue 3, March, 2014, Pages: 400–411, Tom O. McDonald, Marco Giardiello, Philip Martin, Marco Siccardi, Neill J. Liptrott, Darren Smith, Phill Roberts, Paul Curley, Alessandro Schipani, Saye H. Khoo, James Long, Alison J. Foster, Steven P. Rannard and Andrew Owen

    Version of Record online : 1 SEP 2013, DOI: 10.1002/adhm.201300280

  20. You have free access to this content
    Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells


    Volume 52, Issue 1, July 2010, Pages: 115–125, Ana Blas-García, Nadezda Apostolova, Daniel Ballesteros, Daniel Monleón, Jose M. Morales, Milagros Rocha, Victor M. Victor and Juan V. Esplugues

    Version of Record online : 1 MAR 2010, DOI: 10.1002/hep.23647